Brief: Beam Therapeutics Q4 EPS USD 1.73
27/02/2024 11:37
Feb 27 (Reuters) - Beam Therapeutics Q4 net income USD 142.797 million vs. IBES estimate USD -83.5 million. * Q4 EPS USD 1.73 vs. IBES estimate USD -1.01 * Q4 operating expenses USD 183.334 million * Q4 pretax profit USD 144.163 million vs. IBES estimate USD -78.7 million * Q4 operating income USD 132.858 million vs. IBES estimate USD -107.1 million
Recent news on Beam Therapeutics
See all newsBeam Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Beam Therapeutics Q1 net loss narrows beating analyst estimates
U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings
U.S. STOCKS ON THE MOVE-BWX, Generac, Cintas
U.S. STOCKS ON THE MOVE-Arm, On Holding, Sarepta